Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence.
North America is the largest supplier and consumer of Methadone Hydrochloride with a production market share of 39.7% and a consumption market share of 35.6%.
The second place is Europe, following North America with the production market share of 26% and the consumption market share of 29%. Asia is another important market of Methadone Hydrochloride, enjoying 14.9% sales market share.
Market Competition is not intense, as the players are controlled by country. Eli Lilly, Sanofi, Roxane Laboratories, and Mallinckrodt are the major players in the industry. They have formed global market channel of the industry. However, with the medicine level developing, there will be more competitors in the future.
The global Methadone Hydrochloride market is valued at 52 million US$ in 2017 and will reach 76 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2018-2025.
The major manufacturers covered in this report
Tianjin Central Pharma
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Methadone Hydrochloride Tablet
Methadone Hydrochloride Oral Solution
The study objectives of this report are:
To analyze and study the global Methadone Hydrochloride sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Methadone Hydrochloride manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Methadone Hydrochloride are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Methadone Hydrochloride Manufacturers
Methadone Hydrochloride Distributors/Traders/Wholesalers
Methadone Hydrochloride Subcomponent Manufacturers
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Methadone Hydrochloride market, by end-use.
Detailed analysis and profiles of additional market players.